1. Home/
  2. Compounds/
  3. erlotinib:PLX-4032 (2:1 mol/mol)

erlotinib:PLX-4032 (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2erlotinib:PLX-4032 (2:1 mol/mol)
PharmacoGx erlotinib:PLX-4032 (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to erlotinib:PLX-4032 (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA LPCAT2 CTRPv2 pan-cancer AAC 0.22 4e-08
mRNA FAM83B CTRPv2 pan-cancer AAC 0.22 2e-06
mRNA GALNT3 CTRPv2 pan-cancer AAC 0.22 5e-07
mRNA SOX10 CTRPv2 pan-cancer AAC 0.22 0.0003
mRNA S100A9 CTRPv2 pan-cancer AAC 0.22 4e-09
mRNA DSG2 CTRPv2 pan-cancer AAC 0.22 2e-06
mRNA KLC3 CTRPv2 pan-cancer AAC 0.22 2e-07
mRNA TGFA CTRPv2 pan-cancer AAC 0.22 2e-07
mRNA PKP3 CTRPv2 pan-cancer AAC 0.22 7e-06
mRNA PHLDA3 CTRPv2 pan-cancer AAC 0.23 6e-08
Download CSV